HAWAII MINORITY BASED CCOP

夏威夷少数民族社区临床肿瘤学的研究对象 计划(MB-CCOP)将在过去几年成功的基础上 为夏威夷癌症患者和高危患者提供NCI临床试验 个人，以减少癌症的发病率、发病率和 死亡率：1：为扩大临床研究提供支持 夏威夷州，一个多种族的人口，大多数 非高加索癌症患者；2.带来 最新的治疗和癌症防治研究 向本社区的少数族裔个人提供援助；3.增加 初级保健提供者和其他专家的参与 在癌症治疗、预防和控制研究中；4.促进 在NCI批准的服务不足人群中更广泛地参与 研究；5.加强目前存在的业务基础 在这一人群中推广癌症预防和控制研究。 夏威夷癌症研究中心将作为行政管理机构 MB-Coop总部，用于指导招聘、应计和数据 NCI批准的癌症治疗和控制临床的管理 审判。西南肿瘤学研究组，安德森大学医学博士 罗切斯特癌症中心、妇科肿瘤学小组和 儿科肿瘤组是夏威夷MB-CCOP的研究基地。这个 参加会议的医生包括岛上所有的肿瘤学家 瓦胡岛，以及来自其他医疗和非医疗专业人士 特色菜。所有主要的瓦胡岛医院都将作为组成部分 机构。MB-CCOP将允许夏威夷人民，大约75 其中1%是亚洲和太平洋岛民，受益于 获得最先进的癌症治疗和控制 干预措施。

The object of the Hawaii Minority-Based Community Clinical Oncology Program (MB-CCOP) is to build on its past several years' success in providing NCI clinical trails to Hawaii cancer patients and high risk individuals in order to reduce cancer incidence, morbidity, and mortality by: 1: providing support to expand clinical research in the state of Hawaii, a multiethnic population with a majority of non-Caucasian cancer patients; 2. Bring the advantages of state-of-the-art treatment and cancer prevention and control research to minority individuals in their own communities; 3. Increasing the involvement of primary health care providers and other specialists in cancer treatment, prevention and control studies; 4. Facilitating wider participation among underserved populations in NCI-approved research; 5. Strengthening the operational base that currently exists to extend cancer prevention and control research in this population. The Cancer Research Center of Hawaii will serve as the administrative headquarters for the MB-COOP to direct recruitment, accrual, and data management for NCI-approved cancer treatment and control clinical trials. The Southwest Oncology Group, M.D.Anderson, University of Rochester Cancer Center, Gynecologic Oncology Group, and the Pediatric Oncology Group are the Hawaii MB-CCOP research bases. The participating physicians include all oncologists on the island of Oahu, as well as professionals from other medical and nonmedical specialties. All major Oahu hospitals will serve as component institutions. The MB-CCOP will allow the people of Hawaii, about 75 percent of whom are Asian and Pacific Islanders, to benefit from access to state-of-the-art cancer treatment and control interventions.